BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38071340)

  • 1. Blockade of DDR1/PYK2/ERK signaling suggesting SH2 superbinder as a novel autophagy inhibitor for pancreatic cancer.
    Xu H; Tan M; Hou GQ; Sang YZ; Lin L; Gan XC; Cao X; Liu AD
    Cell Death Dis; 2023 Dec; 14(12):811. PubMed ID: 38071340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer-SH2 superbinder-based targeted therapy for pancreatic ductal adenocarcinoma.
    Liu AD; Zhou J; Bi XY; Hou GQ; Li SS; Chen Q; Xu H; Cao X
    Clin Transl Med; 2021 Mar; 11(3):e337. PubMed ID: 33783993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.
    Huang H; Svoboda RA; Lazenby AJ; Saowapa J; Chaika N; Ding K; Wheelock MJ; Johnson KR
    J Biol Chem; 2016 Oct; 291(44):23208-23223. PubMed ID: 27605668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma.
    Aguilera KY; Huang H; Du W; Hagopian MM; Wang Z; Hinz S; Hwang TH; Wang H; Fleming JB; Castrillon DH; Ren X; Ding K; Brekken RA
    Mol Cancer Ther; 2017 Nov; 16(11):2473-2485. PubMed ID: 28864681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin
    Gao C; Chen G; Zhang DH; Zhang J; Kuan SF; Hu W; Esni F; Gao X; Guan JL; Chu E; Hu J
    Cell Mol Gastroenterol Hepatol; 2019; 8(4):561-578. PubMed ID: 31330317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors.
    Stalnecker CA; Grover KR; Edwards AC; Coleman MF; Yang R; DeLiberty JM; Papke B; Goodwin CM; Pierobon M; Petricoin EF; Gautam P; Wennerberg K; Cox AD; Der CJ; Hursting SD; Bryant KL
    Cancer Res; 2022 Feb; 82(4):586-598. PubMed ID: 34921013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (Arg)
    Liu AD; Xu H; Gao YN; Luo DN; Li ZF; Voss C; Li SSC; Cao X
    J Exp Clin Cancer Res; 2018 Jul; 37(1):138. PubMed ID: 29976230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discoidin Domain Receptor 1 (DDR1) Is Necessary for Tissue Homeostasis in Pancreatic Injury and Pathogenesis of Pancreatic Ductal Adenocarcinoma.
    Ruggeri JM; Franco-Barraza J; Sohail A; Zhang Y; Long D; Pasca di Magliano M; Cukierman E; Fridman R; Crawford HC
    Am J Pathol; 2020 Aug; 190(8):1735-1751. PubMed ID: 32339496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancer.
    Ko S; Jung KH; Yoon YC; Han BS; Park MS; Lee YJ; Kim SE; Cho YJ; Lee P; Lim JH; Ryu JK; Kim K; Kim TY; Hong S; Lee SH; Hong SS
    Am J Cancer Res; 2022; 12(9):4326-4342. PubMed ID: 36225647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-Regulation of DDR1 Induces Apoptosis and Inhibits EMT through Phosphorylation of Pyk2/MKK7 in DU-145 and Lncap-FGC Prostate Cancer Cell Lines.
    Azizi R; Fallahian F; Aghaei M; Salemi Z
    Anticancer Agents Med Chem; 2020; 20(8):1009-1016. PubMed ID: 32275493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis.
    Deng J; Kang Y; Cheng CC; Li X; Dai B; Katz MH; Men T; Kim MP; Koay EA; Huang H; Brekken RA; Fleming JB
    JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34237033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
    Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
    Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition.
    Li X; Roife D; Kang Y; Dai B; Pratt M; Fleming JB
    Oncogene; 2016 Sep; 35(37):4881-90. PubMed ID: 26876211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome.
    Su H; Yang F; Fu R; Trinh B; Sun N; Liu J; Kumar A; Baglieri J; Siruno J; Le M; Li Y; Dozier S; Nair A; Filliol A; Sinchai N; Rosenthal SB; Santini J; Metallo CM; Molina A; Schwabe RF; Lowy AM; Brenner D; Sun B; Karin M
    Nature; 2022 Oct; 610(7931):366-372. PubMed ID: 36198801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.
    Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É
    Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
    Kanteti R; Mirzapoiazova T; Riehm JJ; Dhanasingh I; Mambetsariev B; Wang J; Kulkarni P; Kaushik G; Seshacharyulu P; Ponnusamy MP; Kindler HL; Nasser MW; Batra SK; Salgia R
    Cancer Biol Ther; 2018 Apr; 19(4):316-327. PubMed ID: 29303405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
    Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Chen SY; Hsu YH; Wang SY; Chen YY; Hong CJ; Yen GC
    Phytother Res; 2022 Apr; 36(4):1664-1677. PubMed ID: 35224793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIR506 induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway.
    Sun L; Hu L; Cogdell D; Lu L; Gao C; Tian W; Zhang Z; Kang Y; Fleming JB; Zhang W
    Autophagy; 2017 Apr; 13(4):703-714. PubMed ID: 28121485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.